GlobeNewswire

bp, Aker and Statkraft join forces for offshore wind in the Norwegian North Sea

Share

(OSLO, 14 June 2021) bp today agreed to join Statkraft and Aker Offshore Wind in a consortium bidding to develop offshore wind energy in Norway. 

The partnership – in which bp, Statkraft and Aker Offshore Wind will each hold a 33.3% share – will pursue a bid to develop offshore wind power in the Sørlige Nordsjø II (SN2) licence area.

SN2’s favourable location provides power export access to local and adjacent markets. The consortium also intends to explore opportunities to provide clean power to electrify offshore oil and gas facilities. The partnership would work with local suppliers, building industrial competencies for Norway’s offshore wind market, and contribute toward value creation in the Nordic and European energy market.

The consortium brings together the individual companies’ strong technical skills and deep experience in offshore energy projects, covering the full value chain from development to the delivery of offshore renewable energy to market.

bp has interests in the offshore wind sector in both the US and UK and a longstanding onshore wind business in the US. It brings strong North Sea development and operating experience, international energy trading capabilities and a disciplined financial framework to the partnership.

Dev Sanyal, bp’s executive vice president of gas and low carbon energy, said: “bp aims to grow our renewables business at scale and we see great opportunities in offshore wind energy. We have decades of offshore experience in the North Sea and will also bring our extensive trading capabilities and strong relationships in Europe. Coming together with Aker and Statkraft, we believe this consortium will be ideally positioned to effectively and efficiently grow and deliver clean power for European markets, as well as strengthen the supply to Norway when needed.”

As Europe’s largest producer of renewable energy, Statkraft’s expertise in energy management and its experience and competence in wind farm development and operations provide a foundation for success in developing SN2.

Christian Rynning-Tønnesen, chief executive of Statkraft, said: “We have extensive capability from the development and operation of onshore wind around the world and experience in significant offshore wind projects in the United Kingdom and Ireland. Strong growth, decreasing technology costs and the involvement of industrial and financial players all indicate the rising role that offshore wind will play in Europe. Our partnership with Aker and bp will create significant value and contribute towards Europe’s energy transition.”

Aker brings to the project its learnings and know-how from five decades of designing and executing offshore projects in the North Sea as a supplier, developer and operator. Aker Horizons will work closely with the consortium on topics including strategy and financing, and the partnership will also benefit from the broad capabilities of other Aker companies, including Cognite and Aker Solutions.

Kristian Røkke, Chairman of Aker Offshore Wind and CEO of Aker Horizons, added: “Our partnership has the potential to redefine Norway’s position as an energy nation, and the consortium’s joint capabilities are building blocks to lead the energy transition. Together with Statkraft and bp we will work to develop the Norwegian offshore wind industry, reduce emissions and create new jobs.”

With bp joining the Norwegian consortium, energy cooperation between Norway and the United Kingdom is also further strengthened.

About bp

bp’s purpose is to reimagine energy for people and our planet, and our ambition is to be a net ‎zero company by 2050, or sooner, and help the world get to net zero. bp’s strategy is to transform into an Integrated Energy Company focused on delivering solutions for customers and this will see bp growing net developed renewable generating capacity to 20GW by 2025 and 50GW by 2030.

www.bp.com

About Statkraft

Statkraft is a leading company in hydropower internationally and Europe’s largest generator of renewable energy. The Group produces hydropower, wind power, solar power, and supplies district heating. Statkraft is a global company in energy market operations. Statkraft has 4,500 employees in 17 countries.

www.statkraft.com

About Aker Horizons

Aker Horizons exercises active ownership in companies within renewable energy and green technology to limit and reduce greenhouse gas emission, while providing substantial value creation over time. Aker Horizons’ portfolio platform includes investments in the listed companies Aker Offshore Wind and Aker Carbon Capture, as well as in Mainstream Renewable Power and the listed company Aker Clean Hydrogen. The sunrise portfolio includes ongoing initiatives and opportunities within solar, transmission technology and other ventures.

www.akerhorizons.com

About Aker Offshore Wind

Aker Offshore Wind is an offshore wind developer headquartered in Norway with focus on assets in deep waters. With global operations, the current portfolio consists of development projects and prospects located in Asia, North America and Europe. Aker Offshore Wind effectively deploys cost effective technologies from decades of offshore energy development. The company is majority-owned by Aker Horizons, an investment company dedicated to creating value and reducing emissions from renewable energy and decarbonization technologies. Aker Offshore Wind [AOW-ME] is listed on Euronext Growth in Oslo, Norway.

www.akeroffshorewind.com


For further information, please contact:

Geir Fuglseth, Copmmunication manager, Statkraft AS
E-mail: geir.fuglseth@statkraft.com
Tel: +47 913 70 572

Lars Magnus Günther, Press spokesperson, Statkraft AS
E-mail: lars.gunther@statkraft.com
Tel: +47 912 41 636


Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Novo Nordisk's net profit increased by 10% in the first six months of 20214.8.2021 16:41:41 CEST | Press release

4 August 2021 - Financial report for the period 1 January 2021 to 30 June 2021 Operating profit decreased by 1% in Danish kroner and increased by 9% at constant exchange rates (CER).Sales increased by 5% in Danish kroner and by 12% at CER to DKK 66.8 billion. Sales in International Operations increased by 7% in Danish kroner (13% at CER), and sales in North America Operations increased by 1% in Danish kroner (11% at CER).Sales within Diabetes and Obesity care increased by 5% in Danish kroner to DKK 56.9 billion (13% at CER), driven by GLP-1 growth of 21% in Danish kroner (30% at CER) reflecting the uptake of Ozempic® and Rybelsus®. Obesity care grew by 23% in Danish kroner (34% at CER) and Biopharm sales remained unchanged in Danish kroner (increased by 7% at CER).In June 2021, Wegovy™, semaglutide 2.4 mg, was made available to patients in the US following the approval from the US Food and Drug Administration (FDA) for weight management in adults living with obesity.For the 2021 outloo

Novo Nordisk's net profit increased by 10% in the first six months of 20214.8.2021 16:23:58 CEST | Press release

4 August 2021 - Financial report for the period 1 January 2021 to 30 June 2021 Operating profit decreased by 1% in Danish kroner and increased by 9% at constant exchange rates (CER).Sales increased by 5% in Danish kroner and by 12% at CER to DKK 66.8 billion. Sales in International Operations increased by 7% in Danish kroner (13% at CER), and sales in North America Operations increased by 1% in Danish kroner (11% at CER).Sales within Diabetes and Obesity care increased by 5% in Danish kroner to DKK 56.9 billion (13% at CER), driven by GLP-1 growth of 21% in Danish kroner (30% at CER) reflecting the uptake of Ozempic® and Rybelsus®. Obesity care grew by 23% in Danish kroner (34% at CER) and Biopharm sales remained unchanged in Danish kroner (increased by 7% at CER).In June 2021, Wegovy™, semaglutide 2.4 mg, was made available to patients in the US following the approval from the US Food and Drug Administration (FDA) for weight management in adults living with obesity.For the 2021 outloo

Nexstim to Exhibit at the Texas Association of Neurological Surgeons Annual Meeting4.8.2021 15:00:00 CEST | Press release

Press release, Helsinki, 4 August 2021 at 4 PM(EEST) Nexstim to Exhibit at the Texas Association of Neurological Surgeons Annual Meeting Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will be exhibiting during the annual meeting of the Texas Association of Neurological Surgeons this week, August 5-8, 2021 at the Hyatt Regency Lost Pines Resort & Spa in Lost Pines, Texas. This meeting continues to be a significant opportunity for Nexstim to engage current and prospective users of the Nexstim system. Further information is available on the website www.nexstim.com, or by contacting: Mikko Karvinen, CEO +358 50 326 4101 mikko.karvinen@nexstim.com About Nexstim Plc Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a

ProMIS Neurosciences Issues Chairman’s Memorandum4.8.2021 13:30:00 CEST | Press release

Notes and comments after the first AAIC meeting in the era of approved disease-modifying therapies for Alzheimer’s Disease TORONTO and CAMBRIDGE, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, issued today a Chairman’s memorandum, commenting on highlights of the recent 2021 Alzheimer’s Association International Conference (AAIC) with relevance to ProMIS and summarizing the ProMIS poster/oral presentation contributions to the meeting. “We are in a new era in the fight against Alzheimer’s, ALS, and other neurodegenerative diseases,” stated Eugene Williams, Executive Chairman of ProMIS Neurosciences. “ProMIS and many others have predicted this development and we believe that the Alzheimer’s community will look back on 2021 as a turning point, just as 2010 was a turnin

Aspo Plc will publish its Half year financial report on August 11, 20214.8.2021 12:00:00 CEST | Press release

Aspo Plc Press Release August 4, 2021 at 1 p.m. Aspo Plc will publish its Half year financial report on August 11, 2021 Aspo Plc will publish its Half year financial report for January–June 2021 on Wednesday, August 11, 2021 at approximately 9:30 a.m. EEST. The press conference for analysts, investors and media will be held on Wednesday, August 11, 2021 at 2 p.m. The Half year financial report will be presented by CEO Aki Ojanen. The press conference will be held in Finnish and it can be followed at https://aspo.videosync.fi/2021-q2-results, or by calling +358 9 817 10310 (12219443#) 5 to 10 minutes before the beginning of the press conference. The recording of the event will be available on the company’s website later on the same day. Presentation material will be available at www.aspo.com before the event. Aspo Plc Aki Ojanen CEO For further information, please contact: Keijo Keränen, Group Treasurer, +358 400 955 821, keijo.keranen@aspo.com DISTRIBUTION: Key media www.aspo.com Aspo

Cortus Energy: Sista dag för handel med betalda tecknade units (BTU) och omvandling till aktier och teckningsoptioner av serie TO8 och TO94.8.2021 09:46:34 CEST | Pressemelding

PRESSMEDDELANDE Stockholm, den 4 augusti 2021 Cortus Energy AB (”Cortus Energy” eller ”Bolaget”) har som tidigare kommunicerats genomfört en övertecknad företrädesemission av units om cirka 64,8 MSEK ("Företrädesemissionen"). Företrädesemissionen är nu registrerad hos Bolagsverket ochsista dag för handel med BTU är fredagenden 6augusti 2021. Avstämningsdag för omvandlingen är den 10augusti 2021, varefter BTU kommer att omvandlas till aktier och teckningsoptioner av serie TO8 och TO9. Aktier och teckningsoptioner som tecknades i Företrädesemissionen förväntas vara tillgängliga på tecknarens depå/vp-konto den 12 augusti 2021. Första handelsdag för teckningsoptionerna i serie TO8 och TO9 förväntas vara den 13 augusti 2021. Teckningsoptioner av serie TO8 Teckning av aktier med stöd av teckningsoptioner av serie TO8 sker under perioden från och med den 16 november 2021 till och med den 29 november 2021. Varje teckningsoption av serie TO8 ger rätt att teckna en (1) ny aktie i Bolaget mot kon

On transaction with JSC Olainfarm shares4.8.2021 09:08:00 CEST | Press release

On 3 August 2021 a notification regarding sale of shares has been received from JL Index Ltd., which is a closely related party to Jānis Leimanis, who performs manager's duties at JSC Olainfarm. The notification is attached (in Latvian). Additional information: Jānis Dubrovskis Investor Relations Advisor of JSC Olainfarm Phone: +371 29178878 Email: janis.dubrovskis@olainfarm.com Attachment JL Index darijumi 02.08.2021